Skip to main content
Vireo Growth Inc. logo

Vireo Growth Inc. — Investor Relations & Filings

Ticker · VREO ISIN · CA38238W1032 CSE Manufacturing
Open in API
Filings indexed 543 across all filing types
Latest filing 2025-03-04 Regulatory Filings
Country CA Canada
Listing CSE VREO

About Vireo Growth Inc.

https://vireogrowth.com/

Vireo Growth Inc. is a science-focused cannabis company that cultivates, processes, and distributes medical and adult-use cannabis products. The company emphasizes environmentally friendly cultivation practices, often utilizing greenhouses, and manufactures pharmaceutical-grade cannabis extracts. Vireo Growth operates wholesale and retail business lines, selling its portfolio of branded products through company-owned dispensaries and distribution networks. The company's mission is to provide safe access, quality products, and value to its customers, coupled with a commitment to community support and restorative justice programs.

Recent filings

Filing Released Lang Actions
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document consists entirely of Sarbanes-Oxley Act Section 302 and 906 certifications signed by the CEO and CFO. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report like a 10-K, must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. FY 2024
2025-03-04 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document consists entirely of Sarbanes-Oxley Act Section 302 and Section 906 certifications signed by the CEO and CFO. Per the 'CERTIFICATION RULE' provided in the instructions, documents that are primarily officer certifications or attestations, even when referencing a 10-K, must be classified as Regulatory Filings (RNS) rather than the report itself. FY 2024
2025-03-04 English
News release - English.pdf
Earnings Release Classification · 92% confidence The document is a press release announcing Vireo Growth Inc.’s fourth quarter and full year 2024 financial results, with summary metrics, management commentary, conference call details, and forward-looking statements. It is an initial earnings announcement rather than a full annual or interim report, matching the Earnings Release category. Q4 2024
2025-03-04 English
Other.pdf
M&A Activity Classification · 85% confidence The document is a Form 8-K “Current Report” under the Securities Exchange Act describing “Entry into a Material Definitive Agreement” (an extension of an MOU) concerning a proposed transaction between Vireo Growth and Bill’s Nursery. This is clearly related to M&A activity (a memorandum of understanding for a future transaction), matching the M&A Activity category.
2025-01-27 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 85% confidence The document is a Form 45-106F1 “Report of Exempt Distribution” filed under National Instrument 45-106 (Canadian securities regulations). It is a detailed regulatory compliance filing rather than a press release or presentation. It reports on a private/exempt distribution of shares (a financing event) to regulators (SEDAR+), but is not a simple fundraising announcement, nor a standard investor presentation or earnings release. Therefore it falls under the general “Regulatory Filings” fallback category (RNS).
2025-01-09 English
Other.pdf
Regulatory Filings
2025-01-06 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.